Furthermore, Murthy et al [183] found aβ2GPI IgA titres correlated with clinical features of APS and highlighted the role of IgA aPL directed to the 4th and 5th domain of β2GPI in patients with APS. This evidence concerns the gene CD79A and autoimmune polyendocrinopathy.